-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
DICE Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2023.
- DICE Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $5.5M, a 30.8% increase year-over-year.
- DICE Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $4.39M, a 16.9% decline year-over-year.
- DICE Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.8K, a 130% increase from 2021.
- DICE Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.58K, a 99% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)